Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Mirum Pharmaceuticals (MIRM) Return on Sales (2021 - 2025)

Historic Return on Sales for Mirum Pharmaceuticals (MIRM) over the last 5 years, with Q3 2025 value amounting to 0.02%.

  • Mirum Pharmaceuticals' Return on Sales rose 1800.0% to 0.02% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.09%, marking a year-over-year increase of 2400.0%. This contributed to the annual value of 0.26% for FY2024, which is 6200.0% up from last year.
  • Mirum Pharmaceuticals' Return on Sales amounted to 0.02% in Q3 2025, which was up 1800.0% from 0.05% recorded in Q2 2025.
  • Mirum Pharmaceuticals' 5-year Return on Sales high stood at 18.25% for Q4 2021, and its period low was 9.42% during Q3 2021.
  • Its 5-year average for Return on Sales is 0.44%, with a median of 0.5% in 2023.
  • Over the last 5 years, Mirum Pharmaceuticals' Return on Sales had its largest YoY gain of 75200bps in 2022, and its largest YoY loss of -195600bps in 2022.
  • Mirum Pharmaceuticals' Return on Sales (Quarter) stood at 18.25% in 2021, then tumbled by -107bps to 1.31% in 2022, then surged by 61bps to 0.51% in 2023, then skyrocketed by 53bps to 0.24% in 2024, then soared by 109bps to 0.02% in 2025.
  • Its Return on Sales was 0.02% in Q3 2025, compared to 0.05% in Q2 2025 and 0.13% in Q1 2025.